![](/img/cover-not-exists.png)
Gemtuzumab ozogamicin, mitoxantrone, and etoposide in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapy
Michael Boyiadzis, Robert L. Redner, Anastasios Raptis, Jing-Zhou Hou, Mounzer Agha, Kenneth A. FoonVolume:
90
Language:
english
Pages:
3
DOI:
10.1007/s00277-010-1076-0
Date:
June, 2011
File:
PDF, 71 KB
english, 2011